You are here: Industry Insights > Vertex Pharmaceuticals

News List

CRISPR Therapeutics and Vertex Pharmaceuticals announce FDA RMAT designation granted to CTX001 to tr pharmaceutical-business-review
May 14, 2020
CRISPR Therapeutics and Vertex Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX001.
Vertex joins the new-CEO brigade with Leiden jumping to exec chairman, CMO stepping up fiercepharma
July 28, 2019
Vertex Pharmaceuticals CEO Jeffrey Leiden has overseen big changes at the company since taking the post in 2012, and now he’s handing over the reins.
UK politicians to grill Vertex CEO over CF price drug row pharmaphorum
March 07, 2019
The CEO of Vertex Pharmaceuticals is to give evidence before influential UK politicians on Thursday, who are investigating the ongoing row over the price of cystic fibrosis drugs in England.
EU label for Vertex's cystic fibrosis drug Orkambi expanded again to include even younger children firstwordpharma
January 22, 2019
Orkambi was initially approved in Europe in 2015 for patients with CF ages 12 years and older who have two copies of the F508del mutation and was later expanded to include children ages six to 11 years.